Analysis of competition and the level of dominance in the antidiabetics market of Russia

Introduction. Amid reports of a growing number diabetic patients, the antidiabetics market players positioning is highly important for companies and country’s leadership. The regulatory measures management decisions depend on competitive situation in market. Aim. Analysis changes level dominance markets blood glucose monitors meters. Materials methods. distribution these by product groups, as well commercial public procurement segments has been taken into account. Herfindahl-Hirschman Linda indices, adjusted Hall-Tideman index, concentration ratios SV matrix (strength/variety) were used analysis tools, calculations made basis IQVIA data period from 2004 to 3rd quarter 2022. Results. three foreign that fell B4 G quadrants was detected insulin analogues glucose-lowering drugs most competitive, it RO quadrant more often than other markets, dominant group, depending segment, included domestic with different frequency. both one Russian quadrants, larger companies, identified alimentary tract metabolism products. Several company steadily dominated test strips, meters accessories, lancets. Conclusions. concentrated its segments. results show historical development studied role them, serve foundation studying impact environmental events